𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differences in glycosylation of intracellular proteins between benign and malignant thyroid neoplasms

✍ Scribed by A Krześlak; L Pomorski; Z Gaj; A Lipińska


Book ID
117467805
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
258 KB
Volume
196
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Frequency and degree of aneuploidy in be
✍ Lodewijk J. D. M. Schelfhout; Cees J. Cornelisse; Bernard M. Goslings; Jacob F. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 537 KB

The frequency and degree of aneuploidy in 44 benign and I24 malignant thyroid neoplasms were analyzed by DNA flow cytometry. Single aneuploid cell populations were found in 72% of the undifferentiated carcinomas, 64% of the follicular carcinomas, 24% of the papillary carcinomas and in 24% of the fol

Expression of galectin-3 in fine-needle
✍ Hidenori Inohara; Yuichiro Honjo; Tadashi Yoshii; Shiro Akahani; Jun-ichi Yoshid 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 724 KB

## BACKGROUND. Galectin-3 is a ␤-galactoside-binding protein that has been reported to be expressed preferentially in thyroid malignancies. The current study was designed to substantiate this finding further and to establish a presurgical diagnostic modality of differentiating between benign and ma

Upregulation of HMGA2 in thyroid carcino
✍ Gazanfer Belge; Anke Meyer; Markus Klemke; Käte Burchardt; Corinna Stern; Werner 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB

## Abstract The identification of molecular markers allowing to differentiate between benign and malignant thyroid tumors remains a diagnostic challenge. Herein, we have used the expression of the high mobility group protein gene __HMGA2__ and its protein, respectively, as a possible marker detecti